The Janus of a disease: Diabetes and metabolic dysfunction-associated fatty liver disease Francisco Barrera; Javier Uribe; Nixa Olvares; Paula Huerta; Daniel Cabrera; Manuel Romero-Gómez;

Body weight loss and glycemic control on the outcomes of patients with NAFLD. The role of new antidiabetic agents Diego García-Compeán; Ramesh Kumar; Ángel Noe del Cueto-Aguilera; Héctor Jesús Maldonado-Garza; Jesús Zacarías Villarreal-Pérez;

Similar hepatic outcome by SGLT2i vs. DPP4i for at-risk cohort with CHB & T2DM: a nationwide target trial emulation study Byungyoon Yun; Juyeon Oh; Heejoo Park; Jian Lee; Beom Kyung Kim; Jin-Ha Yoon;